JP2005504829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504829A5 JP2005504829A5 JP2003532646A JP2003532646A JP2005504829A5 JP 2005504829 A5 JP2005504829 A5 JP 2005504829A5 JP 2003532646 A JP2003532646 A JP 2003532646A JP 2003532646 A JP2003532646 A JP 2003532646A JP 2005504829 A5 JP2005504829 A5 JP 2005504829A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- inhibitor
- seq
- camkii
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32657601P | 2001-10-01 | 2001-10-01 | |
| US32801001P | 2001-10-08 | 2001-10-08 | |
| PCT/US2002/031496 WO2003029428A2 (en) | 2001-10-01 | 2002-10-01 | Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504829A JP2005504829A (ja) | 2005-02-17 |
| JP2005504829A5 true JP2005504829A5 (enExample) | 2007-10-18 |
Family
ID=26985461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003532646A Pending JP2005504829A (ja) | 2001-10-01 | 2002-10-01 | 構造的心疾患における心筋機能不全を処置するためのカルモジュリンキナーゼｉｉインヒビターの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7320959B2 (enExample) |
| EP (1) | EP1439849A4 (enExample) |
| JP (1) | JP2005504829A (enExample) |
| KR (1) | KR20040045041A (enExample) |
| CN (1) | CN1599622A (enExample) |
| AU (1) | AU2002341938B2 (enExample) |
| BR (1) | BR0213043A (enExample) |
| CA (1) | CA2462443A1 (enExample) |
| IL (1) | IL161231A0 (enExample) |
| MX (1) | MXPA04003040A (enExample) |
| NO (1) | NO20041331L (enExample) |
| NZ (1) | NZ532327A (enExample) |
| PL (1) | PL369104A1 (enExample) |
| WO (1) | WO2003029428A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080255121A1 (en) * | 2004-11-02 | 2008-10-16 | Dainippon Sumitomo Pharma Co., Ltd. | Combination Drug for Treating Autoimmune Disease |
| CN107402307A (zh) * | 2008-04-09 | 2017-11-28 | B.R.A.H.M.S 有限公司 | 用于预测受损峰值耗氧量的内皮素1原 |
| US8841423B2 (en) * | 2008-04-28 | 2014-09-23 | University Of Iowa Research Foundation | Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II |
| US20090275514A1 (en) * | 2008-05-01 | 2009-11-05 | Anderson Mark E | Use of calmodulin kinase ii inhibitors to treat or prevent heart muscle inflammation |
| WO2010135676A1 (en) * | 2009-05-22 | 2010-11-25 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Engineered biological pacemakers |
| US8440656B2 (en) * | 2009-06-22 | 2013-05-14 | University Of Iowa Research Foundation | Methods of treating pulmonary diseases and disorders by modulating calcium/calmodulin dependent protein kinase II activity |
| EP3603658B1 (en) | 2009-10-05 | 2025-01-08 | Cornell University | Peptide for use in the treatment of heart failure resulting from hypertrophic cardiomyopathy |
| CN105517549B (zh) | 2013-03-06 | 2018-11-23 | 阿略斯泰罗斯医疗公司 | CaMKII抑制剂和其用途 |
| DE102014201651A1 (de) * | 2014-01-30 | 2015-07-30 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Isoxazolderivate zur Verwendung bei der Behandlung und/oder Prophylaxe von Herzerkrankungen |
| CA2960101C (en) | 2014-09-05 | 2024-05-21 | Allosteros Therapeutics, Inc. | Substituted carboline derivative and compositions thereof useful as camkii inhibitors |
| WO2018031771A1 (en) | 2016-08-11 | 2018-02-15 | University Of Iowa Research Foundation | CATIONIC CaMKII INHIBITING NANOPARTICLES FOR THE TREATMENT OF ALLERGIC ASTHMA |
| CN112972447B (zh) * | 2021-03-02 | 2022-09-23 | 扬州大学附属医院 | CaMK II抑制剂在制备预防和/或治疗急性胰腺炎的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601438A (enExample) * | 1968-10-17 | 1970-08-24 | ||
| US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| JP2001509808A (ja) * | 1997-01-31 | 2001-07-24 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 多機能性カルシウム／カルモジュリン−依存性プロテインキナーゼの阻害による不整脈の処置 |
| JP2963986B2 (ja) * | 1997-11-19 | 1999-10-18 | 工業技術院長 | カルモジュリン依存性リン酸化酵素ｉｉの特異的阻害剤 |
-
2002
- 2002-10-01 MX MXPA04003040A patent/MXPA04003040A/es not_active Application Discontinuation
- 2002-10-01 JP JP2003532646A patent/JP2005504829A/ja active Pending
- 2002-10-01 CA CA002462443A patent/CA2462443A1/en not_active Abandoned
- 2002-10-01 NZ NZ532327A patent/NZ532327A/en unknown
- 2002-10-01 WO PCT/US2002/031496 patent/WO2003029428A2/en not_active Ceased
- 2002-10-01 AU AU2002341938A patent/AU2002341938B2/en not_active Ceased
- 2002-10-01 PL PL02369104A patent/PL369104A1/xx not_active Application Discontinuation
- 2002-10-01 KR KR10-2004-7004775A patent/KR20040045041A/ko not_active Withdrawn
- 2002-10-01 EP EP02776099A patent/EP1439849A4/en not_active Withdrawn
- 2002-10-01 IL IL16123102A patent/IL161231A0/xx unknown
- 2002-10-01 BR BR0213043-2A patent/BR0213043A/pt not_active IP Right Cessation
- 2002-10-01 US US10/491,323 patent/US7320959B2/en not_active Expired - Fee Related
- 2002-10-01 CN CNA028241010A patent/CN1599622A/zh active Pending
-
2004
- 2004-03-31 NO NO20041331A patent/NO20041331L/no not_active Application Discontinuation
-
2007
- 2007-11-13 US US11/983,987 patent/US7632815B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101718639B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| KR102159601B1 (ko) | 심방 확장 또는 재형성을 특징으로 하는 질환을 치료하기 위한 nep 억제제 | |
| EP0741567B1 (en) | Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds | |
| CN1248683C (zh) | 二肽基肽酶iv抑制剂在制备治疗2型糖尿病的药物中的用途 | |
| JPH04226914A (ja) | 狭心症治療用バクロフェン | |
| TWI908718B (zh) | 類鐸受體促效劑給藥方案 | |
| JP5643213B2 (ja) | 肥大性心筋症治療用のホスホジエステラーゼタイプＩＩＩ（ＰＤＥＩＩＩ）インヒビターまたはＣａ２＋感作剤 | |
| TW202423423A (zh) | 治療非阻塞性肥厚性心肌病之方法 | |
| KR20210100594A (ko) | 염증성 장애의 치료에 사용하기 위한 벤조이미다졸 유도체 | |
| US20080153827A1 (en) | Method for the Treatment or Prevention of Cardiac Hypertrophy | |
| CN86107813A (zh) | 制备用作强心剂的杂环唑酮类的方法 | |
| CN86107814A (zh) | 制备用作强心剂的噻唑酮的方法 | |
| CN1198617C (zh) | 治疗心脏舒张功能障碍的药物 | |
| JP2005504829A (ja) | 構造的心疾患における心筋機能不全を処置するためのカルモジュリンキナーゼｉｉインヒビターの使用 | |
| JP2000513341A (ja) | 血管拡張剤を使用する肝疾患および類似の徴候の治療法 | |
| JP2003277265A (ja) | ｅＮＯＳ発現に起因する疾患の予防または治療薬 | |
| CN1181699A (zh) | 用于治疗心血管疾病的氨基四氢化萘衍生物 | |
| US9126989B2 (en) | Compound and methods for treating long QT syndrome | |
| Fauville et al. | Severe diltiazem poisoning with intestinal pseudo-obstruction: case report and toxicological data | |
| WO2018192469A1 (en) | Inhibitors of fabp4 and methods of treating arthritis | |
| Murcia et al. | Acute myocardial failure in a young man: Q-fever myocarditis | |
| ES2286595T3 (es) | Combinacion de farmacos antidiabeticos. | |
| NZ190028A (en) | Pharmaceutical compositions containing a dibenzothiazepine | |
| US20060142354A1 (en) | Use of epothilone derivatives for the treatment of hyperparathyroidism | |
| Tsuda | Clinical Improvement in a Young Patient with Hypertrophic Obstructive Cardiomyopathy Treated with Combination Therapy Including Amiodarone. Case Rep Case Ser Cardiol J. October-December 2025; 01 (03): 71-77 |